| 4 min read
A failed RNA drug, major job cuts, a win for myeloma CAR T, and more led the news this week.
| 3 min read
Starting from a defined mechanism can cause discovery programs to miss the best drug candidates.
| 3 min read
Researchers at Erasmus MC and Apeximmune independently identified PLA2G2D as a potential new target for restoring antitumor T cell responses.News
| 7 min read
This year’s awardees were recognized for their achievements in the discovery of orexin, the development of a novel bispecific antibody, and bringing patients to the forefront of drug discovery.
| 4 min read
Whole-exome sequencing identified 36 genes associated with OCD and chronic tic disorders, expanding researchers’ understanding of the biology underlying both conditions.
| 4 min read
The first gene therapy for Huntington's disease submitted to the FDA, an mRNA flu vaccine advances to Phase 3 trials, an antibody drug for celiac disease, and more led the news this week.
| 2 min read
The newly discovered cells protect the tumor by recruiting regulatory T cells to create an immunosuppressive environment.
| 3 min read
The novel stem-cell derived retinal organoid provided a new understanding of the disease by showing that damage to retinal pigment epithelium cells is enough to cause neurodegeneration of photoreceptors.
| 4 min read
Neuro-Innovators is testing whether a combination of existing medicines can promote neuroplasticity and improve outcomes for people living with chronic stroke disability.
| 4 min read
Another FDA-approved blood test for Alzheimer’s disease, a large investment in an epilepsy drug, a win for a monoclonal antibody drug, and more led the news this week.
| 6 min read
Bacteria have been linked to cancer treatment for more than a century. Now researchers are trying to turn them into actual therapies.
| 3 min read
New results from their Phase 2 trials show promise, but there could be issues moving to Phase 3. GSK's functional cure could be approved in the US before then.
